Tag Zoetis

Simperica Trio Label Update

Zoetis Logo

Today is an exciting day for Zoetis as we continue to provide innovations for veterinarians and pet owners alike! I am happy to share that the FDA has approved a new label indication for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets).…

Vanguard Vaccine line Updates

In August, Zoetis informed us that they would begin rolling out new packaging for their vaccine line.   Over the next few months, you’ll notice some changes happening to the Zoetis Petcare vaccines you use in your clinic. Some of these…

Simperica New Prevention Label

 Zoetis today announced that the U.S. FDA has approved a new label indication for Simparica® (sarolaner) Chewables for the prevention of Borrelia burgdorferi in dogs. Simparica is now proven to block the pathogen that causes Lyme disease as a result of…

Vetscan Imagyst – New!

Sharing some information with you on the new Imagyst in house fecal analyzer.  The New In-House Fecal Analyzer uses the fecal centrifugation method to bring clinical pathology to the point of care. The IMAGYST recognizes through Artificial Intelligence, parasite…

ProHeart® 12 Approved

The U.S. Food and Drug Administration (FDA) has approved ProHeart® 12 (moxidectin), the new, first-ever once-yearly injection to prevent heartworm disease (caused by Dirofilaria immitis) in dogs 12 months of age and older. Its unique formulation of moxidectin microspheres provides…